Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Lyn Baranowski

At a glance: Lyn Baranowski is CEO at Avalyn Pharma (AVLN). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $1.1M. On file: 0 purchase lines ($0) and 5 sale lines ($1.5M).

CEO at Avalyn Pharma Inc. (AVLN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M

Lyn Baranowski's InsiderPrint

5 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Lyn Baranowski: 5 trades, 2026 to 20262026: 0 buys, 5 sales

Reading this print: Almost only sells, trading about 5 times a year, typically $149K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (5)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Anne McGeorgeDirector · DNTH · 100% match
  2. Bradley K. SerwinGeneral Counsel · COMP · 100% match
  3. Richard A. MedwayGeneral Counsel · SVV · 100% match
  4. Paul VarkiGeneral Counsel · AVTX · 100% match
  5. Gregory B. HebardCFO · JBL · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 19SEC AVLNAvalyn Pharma Inc. Sell Plan 39,6005,700 held (−87%) $27.76 $1.1M +3.3%
Nov 19SEC AVLNAvalyn Pharma Inc. Sell Plan 5,300400 held (−93%) $28.15 $149K +1.8%
Nov 19SEC AVLNAvalyn Pharma Inc. Sell Plan 400 $29.22 $12K -1.9%
Nov 19SEC AVLNAvalyn Pharma Inc. Sell Plan 6,465735 held (−90%) $27.90 $180K +2.7%
Nov 19SEC AVLNAvalyn Pharma Inc. Sell Plan 735 $28.36 $21K +1.1%
  • Sell

    CEO Lyn Baranowski sold $1.1M of AVLN at $27.76 — cuts the stake by 87%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lyn Baranowski sold $149K of AVLN at $28.15 — cuts the stake by 93%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lyn Baranowski sold $12K of AVLN at $29.22 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lyn Baranowski sold $180K of AVLN at $27.90 — cuts the stake by 90%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lyn Baranowski sold $21K of AVLN at $28.36 — pre-scheduled 10b5-1 plan sale.

Follow Lyn Baranowski

Get one email when Lyn Baranowski files a new purchase or sale. Free.

At most one email a day about Lyn Baranowski, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.